Celularity
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Celularity and other ETFs, options, and stocks.About CELU
Celularity, Inc. is a clinical stage biotechnology company, which engages in the development of off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer and immune and infectious diseases. It operates through the following segments: Cell Therapy, BioBanking, Degenerative Disease, and Other.
CEORobert Joseph Hariri Gordon
CEORobert Joseph Hariri Gordon
Employees123
Employees123
HeadquartersFlorham Park, New Jersey
HeadquartersFlorham Park, New Jersey
Founded2016
Founded2016
Employees123
Employees123
CELU Key Statistics
Market cap45.11M
Market cap45.11M
Price-Earnings ratio-0.53
Price-Earnings ratio-0.53
Dividend yield—
Dividend yield—
Average volume66.49K
Average volume66.49K
High today$1.88
High today$1.88
Low today$1.65
Low today$1.65
Open price$1.86
Open price$1.86
Volume72.88K
Volume72.88K
52 Week high$5.22
52 Week high$5.22
52 Week low$1.00
52 Week low$1.00
Stock Snapshot
With a market cap of 45.11M, Celularity(CELU) trades at $1.72. The stock has a price-to-earnings ratio of -0.53.
On 2025-11-07, Celularity(CELU) stock moved within a range of $1.65 to $1.88. With shares now at $1.72, the stock is trading +4.0% above its intraday low and -8.6% below the session's peak.
Trading activity shows a volume of 72.88K, compared to an average daily volume of 66.49K.
Over the past 52 weeks, Celularity(CELU) stock has traded between a high of $5.22 and a low of $1.00.
Over the past 52 weeks, Celularity(CELU) stock has traded between a high of $5.22 and a low of $1.00.
People also own
Based on the portfolios of people who own CELU. This list is generated using Robinhood data, and it’s not a recommendation.